Last reviewed: June 6, 2026

Last updated: June 6, 2026

Written by: Jay Hastings, CEO of PlexusDx

Jay Hastings is the CEO of PlexusDx, a precision health company focused on genetic testing, blood biomarker insights, and personalized wellness recommendations. He has more than 20 years of experience across healthcare innovation, genomics, laboratory operations, healthcare investing, and strategic finance.

Medically reviewed by: Jayden Lee, PharmD, EMBA

Jayden Lee, PharmD, EMBA, is the PlexusDx Medical Science Liaison with a PharmD and MBA specializing in pharmacogenomics and clinical product development, with a proven ability to bridge the gap between genomic research and practical patient outcomes. Dr. Lee has more than 10 years of professional experience in clinical pharmacy, academia, and research.

This article is part of the PlexusDx Education Hub — science-backed guidance on GLP-1 medications, metabolic health, and precision weight management.

Semaglutide dosing typically ranges from 0.25 mg to 2.4 mg weekly, with 1 mg representing a moderate dose used in many treatment plans. Whether 1 mg is right for you depends on your baseline weight, metabolic response, and treatment duration. PlexusDx offers personalized compounded semaglutide injection therapy starting at $149 per month, with doses adjusted based on your individual needs—and your price stays the same as your dose increases.

Understanding Semaglutide Dosing in Weight Loss Treatment

Semaglutide is a GLP-1 receptor agonist that works by slowing stomach emptying and increasing feelings of fullness. Clinical trials show that participants on semaglutide lose 10-15% of body weight at doses of 1.0 mg weekly, compared to 2-3% in placebo groups. The dose-response curve indicates that higher doses often produce greater weight loss, but 1 mg delivers meaningful results for many patients, particularly those in earlier phases of treatment or with moderate obesity.

Most treatment protocols begin at lower doses—typically 0.25 mg—and increase weekly or bi-weekly until reaching a maintenance dose. A 1 mg dose usually represents the middle tier of this escalation ladder, often reached by week 8-12 of therapy. At this point, many patients report noticeable appetite reduction, improved satiety signals, and steady weight loss momentum.

Clinical Evidence: What 1 mg Semaglutide Can Achieve

Landmark trials including STEP 2 showed that participants using 1 mg weekly semaglutide experienced approximately 11% body weight reduction over 68 weeks, significantly outperforming standard care and diet-only interventions. For a person weighing 250 pounds, this translates to roughly 27 pounds of weight loss at this single dose level. Blood sugar control, cardiovascular markers, and energy levels often improve at this dose threshold, making it both metabolically and psychologically meaningful.

Individual results vary based on adherence, dietary habits, physical activity, and genetic predisposition to GLP-1 signaling. Some patients reach their target weight at 1 mg and maintain on that dose, while others continue escalating for additional results. PlexusDx uses the Precision Peptide Genetic Test to identify how your body responds to GLP-1 pathway activation through markers like GLP1R rs6923761, helping predict whether 1 mg may be optimal for your metabolism or whether further titration may offer better outcomes.

Comparing 1 mg to Other Common Semaglutide Doses

A 0.5 mg weekly dose is often the initial maintenance target, producing 5-8% weight loss for many users. Moving to 1 mg typically adds 3-5 percentage points of additional weight loss, making it a meaningful step up in efficacy without proportionally increasing side effects for most patients. Higher doses like 1.7 mg or 2.4 mg show incremental further gains, but diminishing returns emerge at higher doses for some individuals.

The transition from 0.5 mg to 1 mg is where many patients notice the 'sweet spot'—sufficient appetite suppression to maintain a calorie deficit without overwhelming gastrointestinal effects. Nausea and constipation, common at startup, typically resolve by the time patients reach 1 mg maintenance, as the body adapts to the medication's mechanism of action.

Is 1 mg Right for You? Factors That Matter

Your ideal dose depends on several factors: starting body weight, prior weight loss attempts, tolerance to gastrointestinal side effects, and your target weight loss percentage. Patients with a BMI above 35 and minimal prior GLP-1 exposure often benefit from reaching 1 mg or higher, while those with BMI 27-30 may see goal achievement at lower maintenance doses. Your healthcare provider's assessment of your medical history and metabolic status should guide this decision.

PlexusDx offers compounded semaglutide injection through licensed 503A pharmacies, available to all 50 states without insurance requirements. Starting at $149 per month, PlexusDx adjusts your dose to match your clinical needs—whether that's 0.25 mg, 1 mg, 2 mg, or beyond—while keeping your monthly cost flat. This pricing model removes the barrier between dose optimization and affordability, ensuring you access the right dose without financial penalty.

Managing Side Effects and Optimizing Results at 1 mg

Mild nausea, loss of appetite, and occasional constipation are the most frequently reported side effects when reaching 1 mg, but these typically mild by this dose in most patients. Staying hydrated, eating small frequent meals, and including fiber-rich foods helps manage gastrointestinal adaptation. If side effects persist or worsen at 1 mg, your provider may pause escalation or slightly reduce the dose before advancing further.

Maximizing weight loss at 1 mg requires pairing medication with consistent behavior: tracking protein intake (25-30 grams per meal), staying in a calorie deficit of 500-750 calories daily, and moving your body through both cardio and resistance training. Semaglutide works best as part of a comprehensive lifestyle strategy, not as a standalone intervention. Many PlexusDx patients work with nutrition coaches or behavioral health specialists to reinforce these habits while their medication addresses the neurochemistry of appetite.

When to Stay at 1 mg vs. When to Increase Further

You have reached an ideal maintenance dose when weight loss plateaus for 4+ weeks, you feel satisfied with your progress toward your goal, and you tolerate the dose well without bothersome side effects. If weight loss continues steadily and you have not yet reached your target, continuing to escalate toward 1.7 mg or 2.4 mg may yield additional benefits. Conversely, if you are losing 2-3 pounds per week at 1 mg with good tolerability, remaining at this dose is a reasonable strategy.

The Precision Peptide Genetic Test offered by PlexusDx can inform this decision by revealing your genetic predisposition across GLP-1 and GIPR signaling pathways. Variants in GLP1R (rs6923761) and GIPR (rs1800437) influence how strongly your body responds to semaglutide activation, helping predict whether you are likely a robust responder who may benefit from higher doses, or an efficient responder who achieves excellent results at lower doses.

How Your Genetics Influence GLP-1 Response

Not everyone responds to GLP-1 medications the same way. Genetic variants — including GIPR rs1800437, GLP1R rs6923761, FTO rs9939609, and MC4R rs17782313 — influence how your body processes these medications, how much weight you lose, and how you tolerate side effects. PlexusDx maps 14 pathways, 49 peptides, and 150+ genetic insights to match each patient to the right medication, dose, and lifestyle protocol for their biology. The PlexusDx Precision Peptide Genetic Test ($99 add-on after your first month of treatment) gives your provider precise insight into your peptide genetic predispositions before the first prescription is written.

Access Personalized GLP-1 Care Through PlexusDx

PlexusDx offers six prescription GLP-1 protocols to all 50 states — no membership, no insurance required, async intake or live consult. The Semaglutide Injection starts at $149/mo. Medications are dispensed from licensed 503A compounding pharmacies following strict quality and safety standards. Add a Precision Peptide Genetic Test for $99 to personalize your protocol from day one.

Frequently Asked Questions

Is 1 mg of semaglutide considered a high dose?

No. 1 mg is a mid-range maintenance dose; the maximum approved dose is 2.4 mg weekly. Most patients escalate to 1 mg over 8-12 weeks and remain there long-term, making it a standard therapeutic target rather than a high dose. Many achieve meaningful weight loss at 1 mg without needing further escalation.

How much weight will I lose on 1 mg semaglutide per week?

Average weight loss ranges from 0.5 to 1.5 pounds per week on 1 mg, depending on diet, exercise, and individual metabolism. Clinical trials show approximately 11% total body weight reduction over 68 weeks, which translates to roughly 27 pounds for a 250-pound person. Your personal results will vary based on adherence and genetic factors.

How much does semaglutide injection cost at PlexusDx?

PlexusDx compounded semaglutide injection starts at $149 per month and remains flat across all dose tiers—meaning your price does not increase as your dose increases to 1 mg, 1.7 mg, or beyond. The medication is available to all 50 states without insurance, and HSA/FSA funds are accepted.

What are the side effects of 1 mg semaglutide, and are they tolerable?

Common side effects at 1 mg include mild nausea, decreased appetite, and occasional constipation; most patients experience these mildly or not at all by the time they reach this dose level. Serious side effects are rare. Side effect management through hydration, small meals, and fiber typically resolves discomfort within 1-2 weeks of reaching 1 mg.

Can PlexusDx's genetic test help me know if 1 mg is enough?

Yes. The Precision Peptide Genetic Test identifies variants in GLP1R (rs6923761) and GIPR (rs1800437) that influence how strongly you respond to semaglutide. This helps predict whether you are likely a strong responder (may benefit from higher doses) or an efficient responder (achieve excellent results at 1 mg). The test costs $99 after your first month of treatment.

Related Reading

Pricing and availability current as of June 2026. Compounded GLP-1 medications are not FDA-approved drug products; they are prepared by licensed compounding pharmacies under federal compounding regulations. Compounded semaglutide and tirzepatide are not the same as Wegovy, Ozempic, Zepbound, or Mounjaro. This article is for informational purposes only and does not constitute medical advice. Consult a licensed healthcare provider before starting, stopping, or changing any medication.

Return to the PlexusDx Education Hub for more evidence-based resources on GLP-1 therapy, metabolic health, and personalized weight management.

Medical and Editorial Standards

Medical review process: This article was reviewed for medical accuracy, scientific clarity, evidence alignment, and appropriate discussion of genetics, medications, supplements, biomarkers, and health-related claims.

Sources and evidence: PlexusDx educational content is developed using peer-reviewed research, clinical literature, reputable medical references, and, where applicable, public health or regulatory guidance.

Commercial transparency: PlexusDx offers genetic testing, blood biomarker testing, personalized supplement recommendations, and related precision wellness services. Product mentions are intended to help readers understand available options and should not be interpreted as medical advice.

Important disclaimer: PlexusDx educational content is for informational purposes only and should not be used as a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making decisions about medications, supplements, genetic testing, lab testing, or health-related care.

Real prescribers. Published prices. No surprises.

Licensed providers in all 50 states. Online intake. No insurance, no membership required.

Start My Intake →

~60 seconds · $0 charged until your provider approves